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This paper presents a droplet-based microfluidic platform for miniaturized combinatorial synthesis. As
a proof of concept, a library of small molecules for early stage drug screening was produced.We present
an efficient strategy for producing a 7  3 library of potential thrombin inhibitors that can be utilized
for other combinatorial synthesis applications. Picolitre droplets containing the first type of reagent
(reagents A1, A2,., Am) were formed individually in identical microfluidic chips and then stored off
chip with the aid of stabilizing surfactants. These droplets were then mixed to form a library of droplets
containing reagents A1–m, each individually compartmentalized, which was reinjected into a second
microfluidic chip and combinatorially fused with picolitre droplets containing the second reagent
(reagents B1, B2, ., Bn) that were formed on chip. The concept was demonstrated with a three-
component Ugi-type reaction involving an amine (reagents A1–3), an aldehyde (reagents B1–7), and an
isocyanide (held constant), to synthesize a library of small molecules with potential thrombin inhibitory
activity. Our technique produced 106 droplets of each reaction at a rate of 2.3 kHz. Each droplet had
a reaction volume of 3.1 pL, at least six orders of magnitude lower than conventional techniques. The
droplets can then be divided into aliquots for different downstream screening applications. In addition
to medicinal chemistry applications, this combinatorial droplet-based approach holds great potential
for other applications that involve sampling large areas of chemical parameter space with minimal
reagent consumption; such an approach could be beneficial when optimizing reaction conditions or
performing combinatorial reactions aimed at producing novel materials.
Introduction
Early stage screening for drug discovery, with its inherently low
success rate, demands the capability to efficiently screen large
numbers of compounds with both high speed and minimal
reagent consumption. Combinatorial chemistry is often used as
a method for creating structurally diverse libraries, and robotic
systems are used to increase the throughput of both synthesis and
subsequent screening.1,2 Droplet-based microfluidics offers many
advantages3–6 over conventional microtiter plate techniques that
could provide powerful enhancements to platforms for combi-
natorial chemistry for early stage drug discovery. Using droplets
of picolitre volume as microreactors allows for individual
experiments using six to eight orders of magnitude less starting
material than microtiter plate approaches, greatly reducing
reagent consumption and improving efficiency through auto-
mation and online analysis. In addition to the benefits of mini-
aturization and increased throughput afforded by droplet-based
microfluidics, a large repertoire of downstream microfluidic
droplet manipulation and detection techniques allows complex
multi-stage experiments with multi-dimensional analysis.3–6
Interesting biological applications of droplet-based microfluidics
have been demonstrated, including single-cell analysis7–12 and
directed evolution of enzymes.13 The ability to manipulate
droplets flowing in immiscible fluids within microfluidic channels
also shows potential in chemical synthesis, where the technique
has been used for precipitate forming reactions,14 phase-transfer
reactions,15,16 and biphasic catalysis.17 Most of these applications
in chemical synthesis use identical droplets and do not exploit the
opportunity to use droplets to perform multiple different
synthetic reactions in parallel.
The high throughput and possibilities for process automation
enabled by droplet-based microfluidics hold great promise for its
application to combinatorial chemistry. Elegant methods for
droplet and plug loading using automation have been demon-
strated.8,18–25 However, current methods lack the capability to
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efficiently merge two libraries of reagents to create a combina-
torial product library. Further developments are needed to
extend these capabilities to loading two different libraries of
reagents (A1, A2, ., Am and B1, B2, ., Bn) and subsequently
producing all of the possible A1–m  B1–n combinations.
Combining reagents from libraries A1–m and B1–n to provide all
reaction combinations cannot be achieved efficiently using
standard methods where droplets are kept single file in micro-
fluidic channels, which have typically been previously used for
synthesis in droplets.
Herein, we demonstrate a droplet-based microfluidic platform
for combinatorial library synthesis of potential drug candidates.
We present an efficient strategy for producing a 7  3 library of
potential enzyme inhibitors. The concept was demonstrated
using an Ugi-type three-component reaction involving an amine
(reagents A1–3), an aldehyde (reagents B1–7), and an isocyanide
(kept constant). Previous studies have discovered potent
thrombin inhibitors by screening crude Ugi reaction products
using conventional microtiter plate technology; ‘hits’ from initial
screens were subsequently resynthesized and purified for further
analysis.26,27 Our goal was to increase the efficiency with which
initial screens on crude reaction products can be conducted and
enable reactions to be carried out with reduced quantities of
reagents. Using droplet-based microfluidics, Ugi reactions were
compartmentalized into picolitre volumes, using only 1013 mol
of reagents per droplet, six orders of magnitude lower than
previous microtiter plate synthesis. Droplets containing the first
type of reagent (reagents A1, A2, ., Am) were formed individ-
ually in poly(dimethylsiloxane) (PDMS) microfluidic devices and
then mixed to form a library of droplets containing reagents
A1–m. This library was then combinatorially fused with droplets
containing the second reagent (reagents B1, B2, ., Bn). The
library, compartmentalized in droplets, is then ready for further
downstream applications such as enzymatic assays to screen for
biological activity. This platform could also be used for applica-
tions outside of medicinal chemistry, for example combinatorial
synthesis aimed at producing novel materials. Our approach
could also provide an efficient way to screen different reaction
conditions, allowing for many parameters to be manipulated
simultaneously to determine the ideal combination of reagents. In
summary this technique allows large areas of chemical parameter
space to be sampled with minimal reagent consumption.
Materials and methods
Reagent solutions
All reagents were used as received. Starting materials for the Ugi-
type reaction came from the following suppliers: 1, 2, 4, 5, 9, and
10 from Aldrich; 6, 7, and 8 from Acros Organics; 3 from Alfa
Aesar; and isocyanide 11 from Specs. Amines 8 and 10 were sold
as a dihydrochloride, and 9 was sold as a sulfate salt. Solutions
for amine droplet formation contained 100 mM of amine (8–10)
and 100 mM triethylamine (TEA) in 70% methanol and 30%
water, except for 9 where 60% methanol and 40% water were
used due to solubility. Aldehyde/isocyanide solutions contained
50 mM aldehyde (1–7) and 50 mM isocyanide (11) in 60%
methanol, 30% water, and 10% triethylene glycol monomethyl
ether.
Plug loading
Plugs of the aldehyde/isocyanide solution (15 mL) were loaded
into PTFE tubing (0.30 mm ID, 0.76 mm OD, Fisher) connected
to a 0.4  16 mm Neolus needle (Terumo) and a glass syringe
(Hamilton) using a syringe pump. Aqueous reagent plugs were
separated by 5 mL plugs of 0.05 wt% EA-surfactant (RainDance
Technologies), which is a polyethylene glycol–perfluoropolyether
(PFPE–PEG–PFPE) amphiphilic tri-block copolymer,28 in Flu-
orinert FC-40 (3M).
Device fabrication
Microfluidic channels were fabricated in PDMS (Sylgard 184,
Dow Corning) using soft lithography.29 PDMS features were
bound to a glass slide (Millipore) by exposing the surfaces to
oxygen plasma and bringing them into contact. Glass slides
coated with indium tin oxide (ITO) on the unbound side (Delta
Technologies) were used in all experiments involving electro-
coalescence. After heating in a 65 C oven for 15 minutes, the
channels were treated with 2 wt% 1H,1H,2H,2H-per-
fluorodecyltrichlorosilane (ABCR) in HFE-7100 (3M), flushed
with Fluorinert FC-40, and placed in a 65 C oven for at least 1 h.
Channels were further treated with 2 wt% 1H,1H,2H,2H-per-
fluorooctyldimethylchlorosilane (ABCR) in HFE-7100, flushed
with FC-40, and placed in a 65 C oven for at least 30 minutes.
Electrodes were fabricated with low-temperature solder (Indal-
loy no. 19, 51% In/32.5% Bi/16.5% Sn, Indium Corporation)
using microsolidics.30,31
Device operation
The device was imaged using a Phantom v4.2 high-speed digital
camera (Vision Research) mounted on an Axiovert 200 inverted
microscope (Carl Zeiss SAS). Fluids were dispensed using glass
syringes (Hamilton) with 0.4  16 mm Neolus needles (Terumo)
connected to PTFE tubing (0.30 mm ID, 0.76 mm OD, Fisher).
The tubing was inserted into inlet holes in the PDMS device.
Flow rates were maintained using Harvard Apparatus PHD
22/2000 syringe pumps.
For amine droplet formation flow rates were adjusted in the
following ranges to form droplets with a volume of 0.8 pL:
10–12 mL h1 (aq) and 120–140 mL h1 (oil). The following
continuous (oil) phase was used for droplet formation: FC-40
containing 2 wt% EA-surfactant and 1 wt% of a novel fluori-
nated surfactant, comprised of a dimorpholinophosphate
(DMP) polar head and PFPE tail (synthetic details to be
described elsewhere). Amine droplets were collected and stored
at 4 C in RDT 1000 Input/Output Vials (RainDance Tech-
nologies) containing 3 wt% EA-surfactant in FC-40 (Fig. 1a).
The Input/Output Vials can be interfaced with microfluidic
devices, syringes, and fluidic connectors, allowing collection and
reinjection of droplets. Amine droplets were mixed through
a 250 mm bore PEEK cross (VICI), into a collection vial, at
50 mL h1 (Fig. 1b). Aldehyde/isocyanide droplets were
produced on the fusion device (Fig. 2) using 25 mL h1 (aq) and
125 mL h1 (oil) while amine droplets were simultaneously
reinjected at 7–12 mL h1 with an oil flow rate of 90–110 mL h1
(flow rates were adjusted in real time to achieve optimal pairing).
To aid synchronization of droplet pairs, an excess (20 to 25%)
This journal is ª The Royal Society of Chemistry 2012 Lab Chip, 2012, 12, 1320–1326 | 1321
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of the larger droplets (containing aldehyde/isocyanide) was
maintained, which passed through the electrodes unfused. For
electrocoalescence, the voltage was applied using an Agilent
A33220A function generator connected to a TREK Mode 623B
amplifier (35 kHz, 200–300 V, sine wave).
Droplet collection and analysis of Ugi-type reaction
As shown in Fig. 2, the fusion device had a collection outlet and
a waste outlet. After fusion, droplets were collected into PTFE
tubing (ID 0.56 mm, OD 1.07 mm, Fisher) at the first device
outlet (collection outlet) by active extraction: a 1 mL syringe
(Omnifix-F, Braun syringe with 0.6  25 mm Neolus needles,
Terumo) was connected to the PTFE tubing used for droplet
storage, and the plunger was actuated with a syringe pump (in
refill mode) to extract droplets into the tubing. The refill rate was
240 mL h1. When the spacer oil was flowing between each
aldehyde/isocyanide plug, the syringe plunger was not actuated,
and the back pressure at the collection outlet was high, causing
the amine droplets to flow passively to the waste outlet. Addi-
tionally, at the end of each aqueous aldehyde/isocyanide plug
some of the plug remained near the pillar structures that were
used as filters (to prevent particles from clogging the micro-
channels) at the aqueous inlet and were not completely removed
as the spacer oil flowed through the inlet. When the next
aqueous plug was introduced to the chip, it merged with the
residual aqueous solution. To minimize cross-contamination, we
discarded droplets produced from the first 25% of each plug,
leading to negligible cross-contamination between plugs. In the
future, modified inlet geometries25 could be used to avoid
Fig. 1 Schematic diagram of the creation of a library of droplets con-
taining reagents A1–3. (a) Droplets containing reagents A1–3 were formed
individually using flow focusing and stored prior to use. (b) The droplets
were then mixed using a polyether ether ketone (PEEK) cross to form
a library of droplets containing reagents A1–3.
Fig. 2 Schematic diagram of combinatorial synthesis in microdroplets with optical micrographs for key droplet manipulations. Droplets containing
reagents B1–nwere formed in a PDMS device via flow focusing from plugs stored in PTFE tubing. These reagent B1–n droplets were paired with reinjected
droplets containing reagents A1–m and fused to produce a library of droplets containing combinatorial mixtures of reagents A1–m and B1–n. Fusion was
achieved using electrocoalescence by applying 200–300 V (35 kHz, sine wave). Fused droplets containing the reaction mixture were extracted and stored
off chip at room temperature for the duration of the reaction. The scale bars are 50 mm.
1322 | Lab Chip, 2012, 12, 1320–1326 This journal is ª The Royal Society of Chemistry 2012
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residual droplets altogether, thus allowing use of the entire
reagent plug.
The collected emulsion was stored in PTFE tubing at room
temperature for 24–27 h for the Ugi-type reaction. The emulsions
were then broken by adding 30 mL of 1H,1H,2H,2H-per-
fluorooctanol (Aldrich) and 60 mL of methanol to each sample.
After centrifuging for 5 min at 13 400 rpm (using an Eppendorf
MiniSpin F45-12-11 centrifuge), the aqueous/organic phase was
analyzed by LC-MS (Thermo Scientific Accela HPLC with
a Surveyor MSQ Plus, Thermo Scientific LCQ Fleet three-
dimensional ion trap mass spectrometer). The Ugi-type reactions
were repeated in bulk and analyzed by LC-MS. Additionally,
bulk reactions were analyzed by HRMS (MicroTOF, Br€uker
Daltonics) within 20–48 h of reaction. Data are provided in
Table S1†.
Results and discussion
Microfluidic platform design and development
To achieve library synthesis in droplets, we integrated multiple
droplet manipulation modules. First reagent A1–m droplets
(0.8 pL) were generated separately using flow focusing.32 6.3 
107 droplets were produced containing each reagent (at 4 kHz)
and stored individually in collection vials containing the
continuous oil phase at 4 C prior to use. Droplets can be used
after formation or stored for up to one week. The polydispersity
of the droplets at formation was <3%, as is typical for emulsions
made using flow focusing,33 and did not change appreciably over
one week. An example of droplets directly after production and
reinjected after 5 days of storage is included in the ESI†, indi-
cating good stability after off-chip storage (videos S1 and S2†).
Before conducting the combinatorial reaction, droplets con-
taining reagents A1–m were mixed to create a library of droplets
(Fig. 1).
To enable sequential delivery of reagents B1–n to the micro-
fluidic device used for combinatorial synthesis (Fig. 2), reagents
B1–n were loaded into plugs within polytetrafluoroethylene
(PTFE) tubing. Plugs were formed by sequentially aspirating
reagents B1–n (15 mL) and an immiscible fluorinated oil (5 mL) to
be used as a spacer phase between each plug. The PTFE tubing
containing the plugs was connected to the aqueous inlet of
a flow-focusing module (Fig. 2), and 2.3 pL droplets were
formed from the reagent B1–n plugs. Simultaneously, the emul-
sion containing reagents A1–m compartmentalized into droplets
was reinjected into the same device (Fig. 2). Pairs of reagent A1–m
droplets and reagent B1–n droplets were then fused using elec-
trocoalescence34–37 (at 2.3 kHz) producing 3.1 pL droplets
containing all combinatorial mixtures of reagents A1–m and B1–n.
Based on the analysis of >500 droplets (using images from 4
different high-speed movies taken at 4 different plugs), 96  3%
of droplet pairs fused upon passing through the electric field; of
the fused droplet pairs 99 2% represented fusion of a reagent A
droplet and a reagent B droplet as intended (1  2% were
unintended fusions of two reagent A droplets with one reagent B
droplet). Unfused droplets (primarily reagent B droplets which
were deliberately maintained in excess; see Materials and
methods) made up 37  3% of the final library. The device
contained two outlets enabling extraction of fused droplets into
PTFE tubing connected to a syringe, which was actuated with
a syringe pump in withdraw mode. When the spacer oil was
flowing between each reagent B plug, the syringe pump was not
actuated and the unfused reinjected reagent A1–m droplets flowed
to the waste outlet (see Materials and methods).
This approach minimizes device complexity by taking advan-
tage of off-chip droplet manipulation. If desired, reagent A1–m
droplets could all be formed on a single device containing
multiple droplet generators, the output of which could be
coupled to an electrocoalescence module for fusion with reagents
B1–n. The approach presented herein allows for more straight-
forward device operation by minimizing the number of liquids
that must be pumped into a single chip simultaneously.
Ugi reactions executed with droplet-based combinatorial
synthesis
To demonstrate the utility of the microdroplet platform for
combinatorial drug synthesis, we used the Ugi multicomponent
reaction (MCR). MCRs involve the combination of three or
more starting materials to form a product.38 Allowing for the
incorporation of wide structural diversity in a single reaction,
MCRs are ideal for creating libraries of drug candidates for
determining structure–activity relationships in early stage
screening and have been used in the synthesis of a variety of drug
candidates.38,39Here we use a three-component Ugi-type reaction
(Scheme 1),26,27 involving an amine, an aldehyde, and an iso-
cyanide, to synthesize a library of small molecules with potential
thrombin inhibitory activity. Thrombin, a serine protease
important in blood clotting, is a target for therapeutic antico-
agulants.40 The ability to detect thrombin inhibition from crude
Ugi-type reaction mixtures, even in the presence of unreacted
starting material, has been demonstrated in previous work con-
ducted in microtiter plates.26,27
We performed reactions with aldehydes 1–7 and amines 8–10,
keeping isocyanide 11 constant, to form a 7  3 library of
possible thrombin inhibitors (Fig. 3). To achieve this synthesis in
microdroplets, droplets containing amines 8–10 and equimolar
triethylamine (reagents A1–3) were preformed, mixed, and rein-
jected into a fusion device. Droplets containing aldehydes 1–7
and isocyanide 11 in a 1 : 1 molar ratio (reagents B1–7) were
formed from preloaded plugs and fused with the reinjected amine
droplets. This 7  3 library is a subset of a larger library of
thrombin inhibitor candidates previously synthesized and
screened for thrombin inhibition by Illgen et al. using conven-
tional microtiter plate technology.27Although these reactions are
typically low yielding (an isolated yield of 18% was achieved in
optimized larger scale synthesis of the most potent inhibitor as
a racemic mixture27), for the purposes of early stage drug
screening Illgen et al. demonstrated that yield is not essential,
discovering novel thrombin inhibitors by first screening crude
Scheme 1 Ugi-type three-component reaction for library synthesis.
This journal is ª The Royal Society of Chemistry 2012 Lab Chip, 2012, 12, 1320–1326 | 1323
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Ugi-type reaction products for inhibitory activity. Selected ‘hits’
from the initial screen of crude products were then resynthesized
and purified by conventional bulk methods to precisely evaluate
potency.27 The goal of our work is to produce the crude reaction
products for the initial screen with greater efficiency and reduced
reagent consumption. We chose starting materials that provide
a wide range of structural diversity and include a known 2 nM
thrombin inhibitor,27 produced by reacting 7, 8, and 11.
Surfactant formulations for formation of stable solvent droplets
In order to conduct the Ugi-type reaction in droplets, we first
developed conditions for the reproducible formation of stable
droplets containing the reagents and solvents. We desired to
manipulate the droplets both on and off chip, requiring excellent
stability to coalescence. We chose to use a fully fluorinated oil,
Fluorinert FC-40 (3M), as carrier since perfluorinated oils are
immiscible with both aqueous and organic phases, and non-
fluorinated compounds are highly insoluble in fluorinated
oils,41,42 preventing partitioning of the compounds into the oil.
Fluorinated oil and surfactants have previously been used to
produce stable fully aqueous droplets that can be taken off chip
and subsequently reinjected.7,28,43 However, to solubilize the
structurally diverse aldehyde starting materials, a solvent
mixture consisting of methanol, water, and triethylene glycol
monomethyl ether (in a 6 : 3 : 1 volumetric ratio) was used. We
therefore developed continuous phase formulations to allow
reliable formation of droplets containing this solvent mixture
and high droplet stability.
After testing a variety of surfactant formulations (Fig. 4), we
found that a mixture of 2 wt% EA-surfactant (RainDance
Technologies), which is a polyethylene glycol–perfluoropolyether
amphiphilic tri-block copolymer (PFPE–PEG–PFPE),28 and
1 wt% of a novel fluorinated surfactant, comprised of a dimor-
pholinophosphate (DMP) polar head and PFPE tail, in FC-40
fluorinated oil allowed for reproducible droplet formation
(Fig. 4d) and stability at the device outlet (Fig. 4e). Although
droplets could be formed with the surfactant formulations shown
in Fig. 4a and c, mild or severe jetting was observed, respectively;
thus the point of droplet breakup within the channel was not
reproducible. Co-flow resulted when 1 wt% Zonyl FSN-100
surfactant was added to the aqueous phase in addition to 3 wt%
EA-surfactant in the continuous phase (Fig. 4b). Together these
results highlight the importance of surfactants and co-surfactants
in droplet formation as well as stability. Additionally, we found
that silanizing the PDMS channels with a trichlorofluorinated
silane followed by treatment with a monochlorofluorinated
silane (as described in Materials and methods) was necessary for
reproducible droplet formation.
Analysis of reaction products
To simplify analysis of the Ugi-type reaction, separate tubing
was used to collect droplets formed from each aldehyde plug,
resulting in a total of seven samples, each containing droplets
with three different reactions. Droplets containing the complete
Ugi-type reaction mixture were left to react at room temperature
for 24 h, following conditions for the bulk library synthesis.27
Each of the 21 reactions was also performed under the same
conditions in bulk and analyzed with both liquid-chromatog-
raphy-mass spectrometry (LC-MS) and high resolution mass
spectrometry (HRMS) where possible (see ESI, Table S1†).
To evaluate the presence of the desired product, the emulsion
was broken by addition of 1H,1H,2H,2H-perfluorooctanol
(PFO) and methanol, and centrifugation, after the 24 h reaction
period. After removal of the fluorinated phase, the reaction
mixture was analyzed by LC-MS. LC-MS indicated the presence
of the desired product in 20 out of the 21 reactions as shown in
Table 1. The one reaction that did not occur in droplets (reaction
of 2, 9, and 11) also did not occur when the reaction was per-
formed under bulk conditions. The retention times and masses
from the bulk reactions showed close correspondence with those
in droplets (typically within 0.05 min and 0.1 Da, respectively),
and HRMS showed close correspondence with the predicted
values (within the expected error for the analysis method used,
see ESI†).
Hence, we have successfully demonstrated a complete droplet-
based workflow for loading a library of reagents into droplets,
Fig. 3 Aldehyde and amine starting materials for a 7  3 combinatorial
library.
Fig. 4 Development of conditions for solvent droplet formation and
stability. The fluorinated continuous phase composition was varied to
allow for reproducible formation of droplets stable to coalescence.
Droplets contain methanol (60%), water (30%), and triethylene glycol
monomethyl ether (10%). The continuous phase was comprised of FC-40
and 3 wt% EA-surfactant (a and b), 3 wt% DMP–PFPE surfactant (c),
and 1 wt% DMP–PFPE and 2 wt% EA-surfactants (d and e). Droplets
formed with the optimized surfactant mixture are stable to coalescence at
the device outlet (e). In (b), Zonyl FSN-100 (1 wt%) was added to the
aqueous phase. The flow-rates were 30 mL h1 (aq) and 125 mL h1 (oil) in
all cases. The channel surface was treated with trichlorofluorinated silane
andmonochlorofluorinated silane in all cases. The scale bar is 40 mm. The
channels were 15 mm deep.
1324 | Lab Chip, 2012, 12, 1320–1326 This journal is ª The Royal Society of Chemistry 2012
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combining them in a combinatorial manner, and conducting an
Ugi-type three-component reaction in droplets.
Conclusions
In summary we have developed a droplet-based microfluidic
platform for combinatorial synthesis in picolitre droplets. By
combining droplet formation, mixing, reinjection, fusion, and
storage modules, we demonstrated combinatorial synthesis,
performing a total of 20 Ugi-type reactions in droplets. Droplets
of one library of reagents (A1–m) are first taken off chip and
mixed such that the droplet mixture can be reintroduced onto
a second chip and merged with droplets containing reagents B1–n,
created directly on-chip. Sufficient replicate droplets of each
reagent were produced to ensure that all reaction combinations
arise statistically by droplet fusion. Droplets containing the
combinatorial reactions were produced at over 2 kHz. Further-
more, this method drastically reduces reagent consumption,
allowing reactions to be conducted in volumes six orders of
magnitude lower than in microtiter plates and enabling experi-
ments with precious or costly reagents. The approach is appli-
cable to other combinatorial reactions, allowing high throughput
production of diverse chemical structures.
This platform has a number of attractive features. The system
used here for a 7  3 combinatorial library is scalable to make
larger libraries. Additional reactions can be conducted by
producing droplets of additional amines and aldehydes since
subsequent fusion and collection of droplets containing the full
reaction mixture can be conducted with high efficiency once the
reagents are loaded. Automated robotic systems could be used to
produce reagent A1–m droplets
44 and load reagents B1–n into
nanolitre or microlitre reagent plugs separated by oil into PTFE
tubing.18–20,23–25Tomix larger libraries of A1–m droplets (higherm
value), multiple PEEK crosses or mechanical mixing44 could be
used. Furthermore, many droplets containing each reaction are
produced; for the 21 member library here 106 droplets were
produced for each reaction (at a rate of 2.3 kHz). Hence, the
droplet library can be divided into aliquots and each aliquot can
potentially be used to screen the library under different condi-
tions, for example for inhibitory activity against a variety of
enzyme targets.
Screening for enzyme inhibition (or other biological activities)
will likely involve using the droplets created with this combina-
torial synthesis system to deliver compounds to droplets con-
taining target enzymes (or other proteins or cells) and other assay
reagents via droplet fusion34–37 in additional microfluidic systems.
Several droplet-based microfluidic systems for measuring
enzyme kinetics and enzyme inhibition have already been
demonstrated,3–6,45,46 and we have measured thrombin kinetics in
droplets using microfluidic delay lines and high throughput
fluorescence measurements to analyze individual droplets (see
ESI, Fig. S1†). The throughput of many systems for drop
fusion34–37 and for measuring enzyme kinetics and enzyme inhi-
bition45,46 is $kHz ($1000 per second), similar to the frequency
with which droplets containing each reaction are produced using
the system described here (2.3 kHz). For many early screening
applications, knowing the identity of the hit may not be as
important as determining whether or not hits exist within a given
library; in this case, the droplet-based synthesis could be used as
a rough initial screen to be followed up by conventional methods
if ‘hit(s)’ are found within a given library. If determining
compound identity is important, the compound library could be
encoded optically or with particles8,47 or hits could be sorted48–50
and studied using advances in single droplet analysis with mass
spectrometry.51–54 Having demonstrated that thrombin assays
can be performed in droplets on chip (ESI, Fig. S1†) and that our
droplet-based combinatorial synthesis platform successfully
generates known thrombin inhibitors via an Ugi-type reaction
(Table 1), we expect downstream screening for thrombin inhi-
bition in droplets to proceed as observed previously in microtiter
plates.27 The work presented herein describes a complete plat-
form for droplet-based combinatorial synthesis which can be
readily integrated with myriad existing analysis and processing
techniques downstream.
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